Mitochondrial properties of spinal motor neurons in ALS neurodegeneration. - the combined degeneration of both "lower" motor neurons in the brainstem and spinal cord (LMNS) and "upper" motor neurons…
Active Grant Awarded
- Award ID
- RNS152737UZ64Y1
- Recipient
-
The Rockefeller University UEI LHGDNJMZ64Y1
- Awarding agency
-
National Institute of Neurological Disorders and Stroke
National Institutes of Health, Department of Health and Human Services
- Obligated
- $84,750
Award facts
- Assistance listing
- 93.NS1 Neurosciences and Neurological Disorders – Research Projects (RP)
- Completion date 1% complete
- Place of performance
- New York, NY 10065, USA
Award details come from USAspending.gov.
Description
Mitochondrial properties of spinal motor neurons in ALS neurodegeneration. - the combined degeneration of both "lower" motor neurons in the brainstem and spinal cord (LMNS) and "upper" motor neurons (UMNS) in the cerebral cortex is an important hallmark of ALS. Almost all cases of ALS are eventually fatal, and the rapid progression of the disease makes IT particularly terrible, with over 80% of patients dying within five years of diagnosis. No cure exists for ALS and the only available treatments slow disease progression by merely a few months. Therefore, a great need exists for more effective and specific therapies that can stop or even reverse neurodegeneration. Innovation for such therapies will only arise from a better understanding of the molecular mechanisms underlying the pathological process, especially since most genes linked to ALS are ubiquitously expressed yet only specific populations of cells degenerate. Understanding why certain cells are uniquely vulnerable and mapping cell type specific pathways that are dysregulated during disease are crucial milestones. The proposed study overcomes this by leveraging cutting edge methods that allow for cell type specific profiling of vulnerable cell populations, building on a recent study describing unique molecular and metabolic pathology of UMNS in a preclinical ALS model. Mitochondrial dysfunction is a common, early phenomenon in ALS. A viral-based strategy to isolate cell type specific mitochondria was used to show that vulnerable UMNS had unique mitochondrial properties and exhibited respiratory failure and metabolic stress in the SOD1G93A model of ALS. In contrast, a separate, highly similar population of cortical cells that were resistant to degeneration exhibited metabolic flexibility and redox defense, able to maintain bioenergetic function in disease. This small research project aims to extend these observations to the vulnerable LMNS. Aim 1 of this grant will employ an integrative approach to query the functional, metabolic, and biochemical properties of LMN mitochondria during disease progression in the SOD1G93A preclinical ALS model. These results will be compared with the previous data from UMNS to ask if there are convergent mitochondrial signatures between separate vulnerable populations. Aim 2 will leverage histological methods for a detailed anatomical analysis of postmortem tissue from ALS patients to validate the translational impact of the results of aim 1. Results from this study will yield novel mechanisms underlying selective vulnerability in ALS.
Quick answers
Who received award RNS152737UZ64Y1?
RNS152737UZ64Y1 was awarded to The Rockefeller University by National Institute of Neurological Disorders and Stroke (National Institutes of Health) on November 16, 2026.
How much is award RNS152737UZ64Y1 worth?
$84,750 has been obligated on RNS152737UZ64Y1.
On GovTribe
See this award's full record
- Every transaction and subaward
- The recipient's other awards and teaming partners
- Similar grant awards
- Ask GovTribe AI about this award